EXI1:F:F-iShares SLI UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 147.56

Change

-6.42 (-4.17)%

Market Cap

N/A

Volume

30.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-7.14 (-1.30%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.71 (-1.40%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.68 (-1.22%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.22 (-1.46%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

-0.87 (-0.89%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-1.70 (-0.74%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

-0.09 (-1.16%)

USD 41.48B
0ZC:F Zscaler Inc

+5.34 (+2.98%)

USD 37.92B
BSND:F Danone SA

+0.10 (+0.71%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-1.44 (-1.15%)

USD 24.77B

ETFs Containing EXI1:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.23% 77% C+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.23% 77% C+ 70% C-
Trailing 12 Months  
Capital Gain 6.90% 60% D- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.90% 58% F 52% F
Trailing 5 Years  
Capital Gain 84.22% 62% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 84.22% 62% D 48% F
Average Annual (5 Year Horizon)  
Capital Gain 10.14% 68% D+ 64% D
Dividend Return 10.14% 65% D 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.25% 56% F 86% B+
Risk Adjusted Return 82.83% 81% B- 86% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike